ABT vs. META: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ABT and META, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Overview
META’s market capitalization of 1,807.70 billion USD is significantly greater than ABT’s 233.90 billion USD, highlighting its more substantial market valuation.
META carries a higher beta at 1.27, indicating it’s more sensitive to market moves, while ABT (beta: 0.74) exhibits greater stability.
| Symbol | ABT | META |
|---|---|---|
| Company Name | Abbott Laboratories | Meta Platforms, Inc. |
| Country | US | US |
| Sector | Healthcare | Communication Services |
| Industry | Medical - Devices | Internet Content & Information |
| CEO | Robert B. Ford | Mark Elliot Zuckerberg |
| Price | 134.44 USD | 719.01 USD |
| Market Cap | 233.90 billion USD | 1,807.70 billion USD |
| Beta | 0.74 | 1.27 |
| Exchange | NYSE | NASDAQ |
| IPO Date | March 17, 1980 | May 18, 2012 |
| ADR | No | No |
Historical Performance
This chart compares the performance of ABT and META by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period.
Data is adjusted for dividends and splits.
Profitability
Return on Equity
ABT
30.76%
Medical - Devices Industry
- Max
- 49.04%
- Q3
- 9.53%
- Median
- -7.46%
- Q1
- -32.83%
- Min
- -82.64%
In the upper quartile for the Medical - Devices industry, ABT’s Return on Equity of 30.76% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
META
38.69%
Internet Content & Information Industry
- Max
- 42.68%
- Q3
- 9.10%
- Median
- 3.28%
- Q1
- -14.17%
- Min
- -26.11%
In the upper quartile for the Internet Content & Information industry, META’s Return on Equity of 38.69% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Return on Invested Capital
ABT
19.13%
Medical - Devices Industry
- Max
- 21.88%
- Q3
- 6.63%
- Median
- -1.11%
- Q1
- -21.08%
- Min
- -51.95%
In the upper quartile for the Medical - Devices industry, ABT’s Return on Invested Capital of 19.13% signifies a highly effective use of its capital to generate profits when compared to its peers.
META
26.21%
Internet Content & Information Industry
- Max
- 31.34%
- Q3
- 14.95%
- Median
- 3.03%
- Q1
- -6.25%
- Min
- -25.52%
In the upper quartile for the Internet Content & Information industry, META’s Return on Invested Capital of 26.21% signifies a highly effective use of its capital to generate profits when compared to its peers.
Net Profit Margin
ABT
31.89%
Medical - Devices Industry
- Max
- 44.80%
- Q3
- 9.77%
- Median
- -5.53%
- Q1
- -29.37%
- Min
- -87.68%
A Net Profit Margin of 31.89% places ABT in the upper quartile for the Medical - Devices industry, signifying strong profitability and more effective cost management than most of its peers.
META
39.11%
Internet Content & Information Industry
- Max
- 39.11%
- Q3
- 15.31%
- Median
- 4.00%
- Q1
- -6.97%
- Min
- -36.95%
A Net Profit Margin of 39.11% places META in the upper quartile for the Internet Content & Information industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin
ABT
16.97%
Medical - Devices Industry
- Max
- 30.13%
- Q3
- 13.12%
- Median
- 3.47%
- Q1
- -24.42%
- Min
- -80.56%
An Operating Profit Margin of 16.97% places ABT in the upper quartile for the Medical - Devices industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
META
42.92%
Internet Content & Information Industry
- Max
- 42.92%
- Q3
- 15.51%
- Median
- 2.63%
- Q1
- -6.98%
- Min
- -18.41%
An Operating Profit Margin of 42.92% places META in the upper quartile for the Internet Content & Information industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | ABT | META |
|---|---|---|
| Return on Equity (TTM) | 30.76% | 38.69% |
| Return on Assets (TTM) | 16.58% | 23.78% |
| Return on Invested Capital (TTM) | 19.13% | 26.21% |
| Net Profit Margin (TTM) | 31.89% | 39.11% |
| Operating Profit Margin (TTM) | 16.97% | 42.92% |
| Gross Profit Margin (TTM) | 55.89% | 81.75% |
Financial Strength
Current Ratio
ABT
1.78
Medical - Devices Industry
- Max
- 12.68
- Q3
- 6.30
- Median
- 4.05
- Q1
- 1.85
- Min
- 0.01
ABT’s Current Ratio of 1.78 falls into the lower quartile for the Medical - Devices industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
META
2.66
Internet Content & Information Industry
- Max
- 7.37
- Q3
- 3.97
- Median
- 2.42
- Q1
- 1.67
- Min
- 0.33
META’s Current Ratio of 2.66 aligns with the median group of the Internet Content & Information industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio
ABT
0.27
Medical - Devices Industry
- Max
- 2.34
- Q3
- 1.09
- Median
- 0.37
- Q1
- 0.08
- Min
- 0.00
ABT’s Debt-to-Equity Ratio of 0.27 is typical for the Medical - Devices industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
META
0.27
Internet Content & Information Industry
- Max
- 0.55
- Q3
- 0.49
- Median
- 0.14
- Q1
- 0.03
- Min
- 0.00
META’s Debt-to-Equity Ratio of 0.27 is typical for the Internet Content & Information industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio
ABT
15.39
Medical - Devices Industry
- Max
- 18.18
- Q3
- 7.53
- Median
- 0.85
- Q1
- -9.80
- Min
- -33.94
ABT’s Interest Coverage Ratio of 15.39 is in the upper quartile for the Medical - Devices industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.
META
88.41
Internet Content & Information Industry
- Max
- 26.56
- Q3
- 12.92
- Median
- 3.11
- Q1
- -5.03
- Min
- -16.11
With an Interest Coverage Ratio of 88.41, META demonstrates a superior capacity to service its debt, placing it well above the typical range for the Internet Content & Information industry. This stems from either robust earnings or a conservative debt load.
Financial Strength at a Glance
| Symbol | ABT | META |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 2.66 |
| Quick Ratio (TTM) | 1.27 | 2.66 |
| Debt-to-Equity Ratio (TTM) | 0.27 | 0.27 |
| Debt-to-Asset Ratio (TTM) | 0.16 | 0.18 |
| Net Debt-to-EBITDA Ratio (TTM) | 0.60 | 0.23 |
| Interest Coverage Ratio (TTM) | 15.39 | 88.41 |
Growth
The following charts compare key year-over-year (YoY) growth metrics for ABT and META. These metrics are based on the companies’ annual financial reports.
Revenue Growth
Earnings Per Share (EPS) Growth
Free Cash Flow Growth
Dividend
Dividend Yield
ABT
1.70%
Medical - Devices Industry
- Max
- 3.57%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 1.70%, ABT offers a more attractive income stream than most of its peers in the Medical - Devices industry, signaling a strong commitment to shareholder returns.
META
0.29%
Internet Content & Information Industry
- Max
- 8.40%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 0.29%, META offers a more attractive income stream than most of its peers in the Internet Content & Information industry, signaling a strong commitment to shareholder returns.
Dividend Payout Ratio
ABT
28.92%
Medical - Devices Industry
- Max
- 102.12%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ABT’s Dividend Payout Ratio of 28.92% is in the upper quartile for the Medical - Devices industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
META
7.70%
Internet Content & Information Industry
- Max
- 112.27%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
META’s Dividend Payout Ratio of 7.70% is in the upper quartile for the Internet Content & Information industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
Dividend at a Glance
| Symbol | ABT | META |
|---|---|---|
| Dividend Yield (TTM) | 1.70% | 0.29% |
| Dividend Payout Ratio (TTM) | 28.92% | 7.70% |
Valuation
Price-to-Earnings Ratio
ABT
17.40
Medical - Devices Industry
- Max
- 90.56
- Q3
- 56.92
- Median
- 43.19
- Q1
- 21.79
- Min
- 5.55
In the lower quartile for the Medical - Devices industry, ABT’s P/E Ratio of 17.40 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
META
27.27
Internet Content & Information Industry
- Max
- 56.51
- Q3
- 39.89
- Median
- 18.31
- Q1
- 10.09
- Min
- 0.08
META’s P/E Ratio of 27.27 is within the middle range for the Internet Content & Information industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Forward P/E to Growth Ratio
ABT
1.73
Medical - Devices Industry
- Max
- 6.56
- Q3
- 3.52
- Median
- 2.22
- Q1
- 0.55
- Min
- 0.03
ABT’s Forward PEG Ratio of 1.73 is within the middle range of its peers in the Medical - Devices industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.
META
2.14
Internet Content & Information Industry
- Max
- 4.26
- Q3
- 2.09
- Median
- 0.83
- Q1
- 0.47
- Min
- 0.01
A Forward PEG Ratio of 2.14 places META in the upper quartile for the Internet Content & Information industry. This suggests the stock is potentially expensive compared to its peers relative to its growth forecast, which may warrant caution.
Price-to-Sales Ratio
ABT
5.52
Medical - Devices Industry
- Max
- 15.74
- Q3
- 8.12
- Median
- 3.40
- Q1
- 2.37
- Min
- 0.42
ABT’s P/S Ratio of 5.52 aligns with the market consensus for the Medical - Devices industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
META
10.61
Internet Content & Information Industry
- Max
- 10.83
- Q3
- 6.47
- Median
- 2.35
- Q1
- 0.97
- Min
- 0.66
META’s P/S Ratio of 10.61 is in the upper echelon for the Internet Content & Information industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
Price-to-Book Ratio
ABT
4.81
Medical - Devices Industry
- Max
- 16.65
- Q3
- 8.03
- Median
- 3.73
- Q1
- 1.92
- Min
- 0.65
ABT’s P/B Ratio of 4.81 is within the conventional range for the Medical - Devices industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
META
9.82
Internet Content & Information Industry
- Max
- 12.17
- Q3
- 6.35
- Median
- 2.86
- Q1
- 0.91
- Min
- 0.02
The P/B Ratio is often not a primary valuation metric for the Internet Content & Information industry.
Valuation at a Glance
| Symbol | ABT | META |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.40 | 27.27 |
| Forward PEG Ratio (TTM) | 1.73 | 2.14 |
| Price-to-Sales Ratio (P/S, TTM) | 5.52 | 10.61 |
| Price-to-Book Ratio (P/B, TTM) | 4.81 | 9.82 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 35.14 | 34.56 |
| EV-to-EBITDA (TTM) | 21.49 | 20.01 |
| EV-to-Sales (TTM) | 5.68 | 10.73 |